Investor Presentaiton
APPENDICES - Q1 2022 RESULTS
Q1 2022: KEY TAKEAWAYS
Strong business performance across our 3 business lines
⚫ Office Property Division: nearly stable GRI (€85.7m, +1.4% vs 2021), in a context of dynamic asset rotation
• Healthcare Property Division: a still steadily growing GRI (+14.6%) driven by portfolio growth
• First positive signs of inflation on index-linked rent reviews: +1.3% effect on Q1, expected to rise for the rest of the year
Property Development Division: sales momentum remains strong, economic revenue at €264m, up +6%;
.
new orders up +28% and notarized sales up +5% vs. Q1 2021
A year 2022 well underway
⚫ Offices: office letting market improving, disposals completed to date: more than €400m YTD (incl preliminary agreement)
Healthcare: on going acquisitions in Eurozone, 30% of the investment plan completed to date
• Indexation higher than expected
• Property Development: Very strong residential demand, manageable costs of construction
Continued liability optimisation and expanded use of green finance
• Issuance of a €500m green bond, 8 years, 1.0% coupon
• Sustainable financial instruments: 35% of total gross debt
• Further optimization of Icade Santé's funding structure with the signing of a 5-year €400m RCF and a €300m 12-month bridge-to-bond facility
Accelerating our low carbon ambition
• 3 business units aligned on a 1.5°C pathway/ a commitment towards SBTi to validate 1.5 C pathway
Unchanged priorities - Confirmation of 2022 guidance
ICADE
ODDO SUSTAINABILITY FORUM
INVESTOR PRESENTATION
JUNE 2022
37View entire presentation